Literature DB >> 19657564

Overexpression of VCC-1 gene in human hepatocellular carcinoma cells promotes cell proliferation and invasion.

Xia Mu1, Yao Chen, Shuihai Wang, Xiang Huang, Huazhen Pan, Ming Li.   

Abstract

Vascular endothelial growth factor-correlated chemokine 1 (VCC-1), a novel chemokine, is hypothesized to be associated with carcinogenesis. VCC-1 is expressed in hepatocellular carcinoma (HCC) cells, but its function remains unknown. To investigate the molecular effects of VCC-1 on HCC cells, the HCC cell line SMMC7721 was stably transfected with the recombinant plasmid pcDNA3.1/VCC-1. Our data demonstrated that overexpression of VCC-1 in SMMC7721 cells significantly enhanced the cellular proliferation, invasive ability, and tumor growth, when compared with both empty vector control cells and parental cells. These results strongly suggest that VCC-1 plays an important role in SMMC7721 invasion and tumor growth, and indicate that VCC-1 may serve as a potential biomarker for anti-HCC therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657564     DOI: 10.1093/abbs/gmp051

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  10 in total

1.  CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity.

Authors:  Amanda M Burkhardt; Kenneth P Tai; Juan P Flores-Guiterrez; Natalia Vilches-Cisneros; Karishma Kamdar; Oralia Barbosa-Quintana; Ricardo Valle-Rios; Peter A Hevezi; Joaquin Zuñiga; Moises Selman; André J Ouellette; Albert Zlotnik
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

2.  Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17.

Authors:  José L Maravillas-Montero; Amanda M Burkhardt; Peter A Hevezi; Christina D Carnevale; Martine J Smit; Albert Zlotnik
Journal:  J Immunol       Date:  2014-11-19       Impact factor: 5.422

3.  Cxcl17-/- mice develop exacerbated disease in a T cell-dependent autoimmune model.

Authors:  Marcela Hernández-Ruiz; Shivashankar Othy; Carolina Herrera; Hong-Tam Nguyen; Gerardo Arrevillaga-Boni; Jovani Catalan-Dibene; Michael D Cahalan; Albert Zlotnik
Journal:  J Leukoc Biol       Date:  2019-03-12       Impact factor: 4.962

4.  Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis.

Authors:  M Tessema; D M Klinge; C M Yingling; K Do; L Van Neste; S A Belinsky
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

5.  CXCL17 is a major chemotactic factor for lung macrophages.

Authors:  Amanda M Burkhardt; José L Maravillas-Montero; Christina D Carnevale; Natalia Vilches-Cisneros; Juan P Flores; Peter A Hevezi; Albert Zlotnik
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

Review 6.  Chemokines in chronic liver allograft dysfunction pathogenesis and potential therapeutic targets.

Authors:  Bin Liu; Jing Li; Lu-Nan Yan
Journal:  Clin Dev Immunol       Date:  2013-12-08

Review 7.  CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.

Authors:  Sara Cabrero-de Las Heras; Eva Martínez-Balibrea
Journal:  World J Gastroenterol       Date:  2018-11-14       Impact factor: 5.742

8.  Transcriptome‑wide piRNA profiling in human gastric cancer.

Authors:  Xiandong Lin; Yan Xia; Dan Hu; Qiao Mao; Zongyang Yu; Hejun Zhang; Chao Li; Gang Chen; Fen Liu; Weifeng Zhu; Yi Shi; Huihao Zhang; Jianming Zheng; Tao Sun; Jianying Xu; Herta H Chao; Xiongwei Zheng; Xingguang Luο
Journal:  Oncol Rep       Date:  2019-03-18       Impact factor: 3.906

9.  CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.

Authors:  Li Li; Jing Yan; Jing Xu; Chao-Qun Liu; Zuo-Jun Zhen; Huan-Wei Chen; Yong Ji; Zhi-Peng Wu; Jian-Yuan Hu; Limin Zheng; Wan Yee Lau
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

10.  Ectopic expression of the chemokine CXCL17 in colon cancer cells.

Authors:  Lina Ohlsson; Marie-Louise Hammarström; Gudrun Lindmark; Sten Hammarström; Basel Sitohy
Journal:  Br J Cancer       Date:  2016-02-18       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.